These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15082919)

  • 1. p27 deregulation in breast cancer: prognostic significance and implications for therapy.
    Alkarain A; Jordan R; Slingerland J
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):67-80. PubMed ID: 15082919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer.
    Alkarain A; Slingerland J
    Breast Cancer Res; 2004; 6(1):13-21. PubMed ID: 14680481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1.
    Cariou S; Catzavelos C; Slingerland JM
    Breast Cancer Res Treat; 1998; 52(1-3):29-41. PubMed ID: 10066070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells.
    Zhang Q; Tian L; Mansouri A; Korapati AL; Johnson TJ; Claret FX
    FEBS Lett; 2005 Jul; 579(18):3932-40. PubMed ID: 15996662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.
    Liang J; Zubovitz J; Petrocelli T; Kotchetkov R; Connor MK; Han K; Lee JH; Ciarallo S; Catzavelos C; Beniston R; Franssen E; Slingerland JM
    Nat Med; 2002 Oct; 8(10):1153-60. PubMed ID: 12244302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated expression of p27(Kip1) in human breast cancers.
    Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
    Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.
    Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M
    Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.
    Musgrove EA; Davison EA; Ormandy CJ
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):55-66. PubMed ID: 15082918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.
    Chu I; Sun J; Arnaout A; Kahn H; Hanna W; Narod S; Sun P; Tan CK; Hengst L; Slingerland J
    Cell; 2007 Jan; 128(2):281-94. PubMed ID: 17254967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.
    Tsihlias J; Kapusta L; Slingerland J
    Annu Rev Med; 1999; 50():401-23. PubMed ID: 10073286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
    Shin I; Yakes FM; Rojo F; Shin NY; Bakin AV; Baselga J; Arteaga CL
    Nat Med; 2002 Oct; 8(10):1145-52. PubMed ID: 12244301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.
    Kudo Y; Kitajima S; Ogawa I; Miyauchi M; Takata T
    Oral Oncol; 2005 Feb; 41(2):105-16. PubMed ID: 15695111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
    Lu Y; Zi X; Pollak M
    Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization.
    Viglietto G; Motti ML; Fusco A
    Cell Cycle; 2002; 1(6):394-400. PubMed ID: 12548012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
    Barbareschi M
    Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
    Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
    Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
    Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-erbB2, p27 and G1/S aberrations in human primary breast cancer.
    Lodén M; Perris F; Nielsen NH; Emdin SO; Landberg G
    Anticancer Res; 2003; 23(3A):2053-61. PubMed ID: 12894578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.